Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Psoriasis Insights: Fall Dermatology Week 2022 Meeting Newsroom

April Armstrong, MD, MPH
Conference Coverage
Novel Topical PDE-4 Inhibitors: Challenges in Treating Immune-Mediated Inflammatory Skin Conditions
09/14/2022
Jessica Garlewicz, Associate Digital Editor
On the first day of Fall Dermatology Week 2022, April Armstrong, MD, MPH, addressed challenges in treating psoriasis, atopic dermatitis, and seborrheic dermatitis.
On the first day of Fall Dermatology Week 2022, April Armstrong, MD, MPH, addressed challenges in treating psoriasis, atopic dermatitis, and seborrheic dermatitis.
On the first day of Fall...
09/14/2022
Dermatology
Joel Gelfand, MD, MSCE
Conference Coverage
Derm Week Review: Managing Moderate to Severe Psoriasis: Interleukin Inhibitors
05/11/2022
Jessica Garlewicz, Associate Digital Editor
In his session presented at Dermatology Week 2022, Joel Gelfand, MD, MSCE, discussed the current treatment landscape for psoriasis using recent data on IL-12, IL-23, and IL-17 inhibitors.
In his session presented at Dermatology Week 2022, Joel Gelfand, MD, MSCE, discussed the current treatment landscape for psoriasis using recent data on IL-12, IL-23, and IL-17 inhibitors.
In his session presented at...
05/11/2022
The Dermatologist
Dr Steven Feldman, MD, PhD, at Dermatology Week 2022
Conference Coverage
Derm Week Review: Managing Poor Adherence to Topical Psoriasis Treatments
05/11/2022
Riya Gandhi, MA, Associate Editor
On the first day of Dermatology Week 2022, Steven R. Feldman, MD, PhD, kicked off the first session to “describe how bad adherence is to topical treatments for psoriasis, some of the implications of poor adherence, why adherence is poor, and...
On the first day of Dermatology Week 2022, Steven R. Feldman, MD, PhD, kicked off the first session to “describe how bad adherence is to topical treatments for psoriasis, some of the implications of poor adherence, why adherence is poor, and...
On the first day of Dermatology...
05/11/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

l
Q&As
Dr Mark Lebwohl on Work Productivity and Quality of Life For Psoriasis Patients
05/10/2021
Mark Lebwohl, MD, discussed his recent study, “Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis”.
Mark Lebwohl, MD, discussed his recent study, “Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis”.
Mark Lebwohl, MD, discussed his...
05/10/2021
The Dermatologist
News
Chronic Inflammatory Skin Disease Not Associated With Increased Incidence of Venous Thromboembolism
06/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Dermatologist-diagnosed chronic inflammatory skin disease does not increase the incidence of venous thromboembolism.
Dermatologist-diagnosed chronic inflammatory skin disease does not increase the incidence of venous thromboembolism.
Dermatologist-diagnosed chronic...
06/24/2021
The Dermatologist
Diagnosis and Management
SPONSORED
Diagnosis and Management
04/04/2022
04/04/2022
Dermatology
psoriasis knees
Conference Coverage
Dr Jashin Wu on Biologics For Treating Psoriasis
03/29/2022
Jessica Garlewicz, Associate Digital Editor
Jashin J Wu, MD, FAAD, presented updates and what’s down the pipeline for biologics used to treat psoriasis.
Jashin J Wu, MD, FAAD, presented updates and what’s down the pipeline for biologics used to treat psoriasis.
Jashin J Wu, MD, FAAD, presented...
03/29/2022
Dermatology
News
Short-Term Increases in Ambient Fine Particulate Matter Are Associated With Psoriasis Risk
11/23/2022
Lisa Kuhns, PhD
In a time series analysis, researchers aimed to study the relationship between short-term exposure to PM2.5 and outpatient visits for psoriasis.
In a time series analysis, researchers aimed to study the relationship between short-term exposure to PM2.5 and outpatient visits for psoriasis.
In a time series analysis,...
11/23/2022
Dermatology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Sign Up for eNews!

Dermatology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Dermatology News

psoriasis
News
Dermoscopy in Psoriasis: Clinical Value
07/24/2024
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained significant attention for its utility in evaluating inflammatory skin diseases, such as psoriasis.
Dermoscopy has gained...
07/24/2024
Dermatology
psoriasis
News
Psoriasis as a Systemic Disease: Evidence and Management
07/09/2024
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the pathophysiologic relationship between psoriasis and its common comorbidities.
Researchers explored the...
07/09/2024
Dermatology
psoriasis
News
Cardiovascular Risk Assessment in Psoriasis
06/20/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate...
06/20/2024
Dermatology
psoriasis
News
Nail Psoriasis Association With IL-17
06/07/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate...
06/07/2024
Dermatology
psoriasis
News
Bibliometric Analysis of Metabolomics Trends in Psoriasis
05/13/2024
Jessica Garlewicz, Digital Managing Editor
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a bibliometric analysis of publications on metabolomics in psoriasis from 2011 to 2024.
Researchers conducted a...
05/13/2024
Dermatology
psoriasis
News
Determining the Risk Factors for Joint Damage in Psoriasis
05/01/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the need for early detection of psoriatic arthritis in patients with psoriasis.
Researchers aimed to address the...
05/01/2024
Dermatology
psoriasis
News
CD6-ALCAM Polymorphisms Potentially Modulate Psoriasis Risk and Outcomes
04/24/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate the potential association between polymorphisms in CD6 and ALCAM genes and susceptibility to psoriasis vulgaris.
Researchers aimed to investigate...
04/24/2024
Dermatology
psoriasis
News
The Impact of Pediatric Plaque Psoriasis on Children and Caregivers
04/17/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to evaluate the impact of childhood and adolescent chronic plaque psoriasis on the quality of life of parents and caregivers.
Researchers aimed to evaluate the impact of childhood and adolescent chronic plaque psoriasis on the quality of life of parents and caregivers.
Researchers aimed to evaluate...
04/17/2024
Dermatology
psoriasis
News
Causal Relationship Between Serum Metabolites and Psoriasis Risk
03/28/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to investigate the influence of serum metabolites on the risk of psoriasis using Mendelian randomization analysis.
Researchers aimed to investigate the influence of serum metabolites on the risk of psoriasis using Mendelian randomization analysis.
Researchers aimed to investigate...
03/28/2024
Dermatology
psoriasis
News
Utilization of Clinical Trial Imaging for Accurate Psoriasis Area and Severity Index Prediction
03/20/2024
Jessica Garlewicz, Digital Managing Editor
Researchers leverage longitudinal imaging data from the Ultima 2 clinical trial involving patients with psoriasis undergoing treatment.
Researchers leverage longitudinal imaging data from the Ultima 2 clinical trial involving patients with psoriasis undergoing treatment.
Researchers leverage...
03/20/2024
Dermatology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement